|
|
LETTER TO THE EDITOR |
|
Year : 2019 | Volume
: 8
| Issue : 14 | Page : 121 |
|
Primary B-Cell jejunal maltoma in a young adult male: A case report and review of literature
Mahmood Dhahir Al-Mendalawi
Department of Paediatrics, Al-Kindy College of Medicine, University of Baghdad, Baghdad, Iraq
Date of Submission | 01-May-2018 |
Date of Acceptance | 01-May-2019 |
Date of Web Publication | 04-Oct-2019 |
Correspondence Address: Prof. Mahmood Dhahir Al-Mendalawi P.O. Box 55302, Baghdad Post Office, Baghdad Iraq
Source of Support: None, Conflict of Interest: None | Check |
DOI: 10.4103/nnjcr.nnjcr_15_18
How to cite this article: Al-Mendalawi MD. Primary B-Cell jejunal maltoma in a young adult male: A case report and review of literature. N Niger J Clin Res 2019;8:121 |
Sir,
I read with interest the case report by Ezejiofor et al.[1] on the primary B-cell jejunal maltoma, a rare variety of lymphoma, in a Nigerian patient. The authors described nicely the clinical presentation, results of imaging studies, laparotomy and histopathological findings, and treatment plan in the studied patient. I presume that the rare occurrence of the tumor and its aggressive nature should alert the authors to consider altered immune status in the studied patient. Among conditions associated with altered immune states, human immunodeficiency virus (HIV) infection is of utmost importance. My presumption is based on the following points. It is obvious that individuals infected with HIV are more susceptible to various types of tumors compared to healthy individuals. The increased susceptibility has been suggested to be related to different factors, including immunosuppression, coinfection with oncogenic viruses, and life prolongation secondary to the use of antiretroviral therapy.[2] Among tumors, intestinal lymphoma has been reported among HIV-positive patients.[3],[4] To my knowledge, Nigeria is one among the Sub-Saharan countries importantly facing the serious health consequences of HIV infection. The recently published data pointed out to the substantial HIV seroprevalence (3.2%) in Nigeria.[5] Hence, determining HIV status in the studied patient by the diagnostic battery of blood CD4 count and viral overload estimations was envisaged. If that cluster of tests were to reveal HIV infection, the case in question could be truly regarded as a novel case report. This is because HIV-associated B-cell intestinal maltoma has never been reported in the literature to date.
Financial support and sponsorship
Nil.
Conflicts of interest
There are no conflicts of interest.
References | | |
1. | Ezejiofor IF, Ogbu CC, Onwukamuche ME, Ndukwe CO, Madubuike KC, Menkiti FE, et al. Primary B-cell jejunal maltoma in a young adult male: A case report and review of literature. N Niger J Clin Res 2017;6:57-60. |
2. | Valencia Ortega ME. Malignancies and infection due to the human immunodeficiency virus. Are these emerging diseases? Rev Clin Esp 2018;218:149-55. |
3. | Yehya A, Nesmith G, Srinivasan S. Primary cecal lymphoma in a 44-year-old human immunodeficiency virus patient presenting with abdominal pain. Clin Gastroenterol Hepatol 2009;7:A22. |
4. | Corti M, Boschi A, Del Portillo Á, Méndez N, Campitelli A, Narbaitz M. Intussusception as clinical presentation of primary non-Hodgkin lymphoma of the colon in a HIV-patient. Rev Esp Enferm Dig 2016;108:750-3. |
5. | Awofala AA, Ogundele OE. HIV epidemiology in Nigeria. Saudi J Biol Sci 2018;25:697-703. |
|